Literature DB >> 26175884

In Response to Risks and Pitfalls of Epidural Injections during Management of Lumbar Disc Herniation: Few Comments.

Laxmaiah Manchikanti1, Joshua A Hirsch2.   

Abstract

Entities:  

Year:  2015        PMID: 26175884      PMCID: PMC4500788          DOI: 10.3344/kjp.2015.28.3.219

Source DB:  PubMed          Journal:  Korean J Pain        ISSN: 2005-9159


× No keyword cloud information.

LETTERS TO EDITORS

We appreciate comments on our manuscript of the Comparison of Efficacy Caudal, Interlaminar, and Transforaminal Epidural Injections in Managing Lumbar Disc Herniation: Is One Method Superior to the Other? [1]. There has been extensive information in reference to the spinal cord infarction due to embolization of particulate steroids, but, also due to needle induced vasospasm, mechanical disruption of radiculomedullary arteries and compression from an epidural abscess or hematoma as probable mechanisms of spinal cord injury in patients undergoing various types of epidural injections [2345678910]. However, no such complications were reported in our manuscript [1]. In fact, we have previously demonstrated a lack of complications in our series [11]. The authors might consider reviewing the manuscript by Atluri et al in reference to lumbar transforaminal epidural injections [9]. All the complications reported with lumbar transforaminal epidural injections have been related to the safe or superior triangle. An infraneural approach appears to be the safest approach. In this trial of transforaminal injections, we have utilized an infraneural approach and occasionally a supraneural approach. Further, the majority of the injections were performed at L5 and S1 with a blunt needle [12]. No post lumbar surgery patients were included. These straightforward precautions assist in avoiding the complications. In addition, we also used a nonparticulate steroid initially until it became unavailable. At present, there is no significant evidence to show the efficacy of nonparticulate steroids available in the present format, so we are unable to recommend nonparticulate steroids; however, there was no significant difference between local anesthetic and steroids [121314151617181920]. In fact, the local anesthetic group fared better than the steroid group [12]. Consequently, we would recommend an infraneural approach and initially utilizing local anesthetic and particulate steroid with appropriate selection criteria for optimal results and to avoid any such complications.
  20 in total

Review 1.  Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations.

Authors:  James P Rathmell; Honorio T Benzon; Paul Dreyfuss; Marc Huntoon; Mark Wallace; Ray Baker; K Daniel Riew; Richard W Rosenquist; Charles Aprill; Natalia S Rost; Asokumar Buvanendran; D Scott Kreiner; Nikolai Bogduk; Daryl R Fourney; Eduardo Fraifeld; Scott Horn; Jeffrey Stone; Kevin Vorenkamp; Gregory Lawler; Jeffrey Summers; David Kloth; David O'Brien; Sean Tutton
Journal:  Anesthesiology       Date:  2015-05       Impact factor: 7.892

2.  Safeguards to prevent neurologic complications after epidural steroid injections: analysis of evidence and lack of applicability of controversial policies.

Authors:  Laxmaiah Manchikanti; Frank J E Falco
Journal:  Pain Physician       Date:  2015 Mar-Apr       Impact factor: 4.965

Review 3.  Do Epidural Injections Provide Short- and Long-term Relief for Lumbar Disc Herniation? A Systematic Review.

Authors:  Laxmaiah Manchikanti; Ramsin M Benyamin; Frank J E Falco; Alan D Kaye; Joshua A Hirsch
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

4.  Epidural steroid injections safety recommendations by the Multi-Society Pain Workgroup (MPW): more regulations without evidence or clarification.

Authors:  Laxmaiah Manchikanti; Frank J E Falco; Ramsin M Benyamin; Christopher G Gharibo; Kenneth D Candido; Joshua A Hirsch
Journal:  Pain Physician       Date:  2014 Sep-Oct       Impact factor: 4.965

5.  Lumbar interlaminar epidural injections are superior to caudal epidural injections in managing lumbar central spinal stenosis.

Authors:  Laxmaiah Manchikanti; Frank J E Falco; Vidyasagar Pampati; Joshua A Hirsch
Journal:  Pain Physician       Date:  2014 Nov-Dec       Impact factor: 4.965

6.  Cervical transforaminal epidural steroid injections: more dangerous than we think?

Authors:  Graham C Scanlon; Tobias Moeller-Bertram; Shawn M Romanowsky; Mark S Wallace
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-15       Impact factor: 3.468

Review 7.  Epidural steroid warning controversy still dogging FDA.

Authors:  Laxmaiah Manchikanti; Kenneth D Candido; Vijay Singh; Christopher G Gharibo; Mark V Boswell; Ramsin M Benyamin; Frank J E Falco; Jay S Grider; Sudhir Diwan; Joshua A Hirsch
Journal:  Pain Physician       Date:  2014 Jul-Aug       Impact factor: 4.965

Review 8.  The effectiveness and risks of fluoroscopically guided cervical transforaminal injections of steroids: a systematic review with comprehensive analysis of the published data.

Authors:  Andrew Engel; Wade King; John MacVicar
Journal:  Pain Med       Date:  2013-12-05       Impact factor: 3.750

Review 9.  Efficacy of epidural injections in the treatment of lumbar central spinal stenosis: a systematic review.

Authors:  Laxmaiah Manchikanti; Alan David Kaye; Kavita Manchikanti; Mark Boswell; Vidyasagar Pampati; Joshua Hirsch
Journal:  Anesth Pain Med       Date:  2015-02-01

10.  Comparison of the efficacy of caudal, interlaminar, and transforaminal epidural injections in managing lumbar disc herniation: is one method superior to the other?

Authors:  Laxmaiah Manchikanti; Vijay Singh; Vidyasagar Pampati; Frank Je Falco; Joshua A Hirsch
Journal:  Korean J Pain       Date:  2015-01-02
View more
  1 in total

1.  Changes in inflammatory factors in patients with osteoporotic vertebral compression fracture and influences of rehabilitation training on postoperative functional recovery and inflammation.

Authors:  Yehong Li; Lin Wang
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-06-01       Impact factor: 2.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.